These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2878723)

  • 1. Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
    Manley BS; Alexopoulos D; Robinson GJ; Cobbe SM
    Cardiovasc Res; 1986 Oct; 20(10):705-9. PubMed ID: 2878723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol.
    Cobbe SM; Manley BS
    Cardiovasc Res; 1985 Feb; 19(2):69-75. PubMed ID: 3978667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
    Bonomi L; Perfetti S; Noya E; Bellucci R; Massa F
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Mar; 210(1):1-8. PubMed ID: 35031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
    Gomoll AW; Bartek MJ
    Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol.
    Groh WJ; Gibson KJ; McAnulty JH; Maylie JG
    Circulation; 1995 Jan; 91(2):262-4. PubMed ID: 7805226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E; Lucchesi BR
    Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalol.
    Hicks MN; Cobbe SM
    Cardiovasc Res; 1990 May; 24(5):404-10. PubMed ID: 2372795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
    Salimi M
    Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):240-52. PubMed ID: 2862847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
    Nakaya H; Kimura S; Nakao Y; Kanno M
    Eur J Pharmacol; 1984 Sep; 104(3-4):335-44. PubMed ID: 6149947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic effect of beta-adrenoceptor-blocking drugs in Purkinje fibres of guinea-pig hearts.
    Lemmens-Gruber R; Zilberszac A; Heistracher P
    Arch Int Pharmacodyn Ther; 1996; 331(1):46-58. PubMed ID: 8896710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles.
    Ban T; Sada S; Takahashi Y; Sada H; Fujita T
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):77-85. PubMed ID: 2582279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 16. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol on the rat left atria and portal vein.
    Doggrell SA
    Chirality; 1993; 5(1):8-14. PubMed ID: 8095397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
    Robbiano L; Martelli A; Allavena A; Mazzei M; Gazzaniga GM; Brambilla G
    Cancer Res; 1991 May; 51(9):2273-9. PubMed ID: 1673086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of three beta-adrenoceptor blocking drugs on isolated preparations of skeletal and cardiac muscle.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1974 Oct; 52(2):275-81. PubMed ID: 4155991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.